Intervention Review

Bromocriptine for idiopathic oligo/asthenospermia

  1. Patrick Vandekerckhove1,*,
  2. Richard Lilford2,
  3. Andy Vail3,
  4. Edward Hughes4

Editorial Group: Cochrane Gynaecology and Fertility Group

Published Online: 21 OCT 1996

Assessed as up-to-date: 1 APR 1996

DOI: 10.1002/14651858.CD000152

How to Cite

Vandekerckhove P, Lilford R, Vail A, Hughes E. Bromocriptine for idiopathic oligo/asthenospermia. Cochrane Database of Systematic Reviews 1996, Issue 4. Art. No.: CD000152. DOI: 10.1002/14651858.CD000152.

Author Information

  1. 1

    St Mary's Hospital, IOW Healthcare NHS Trust, Isle of Wight, UK

  2. 2

    University of Birmingham, Department of Public Health and Epidemiology, Birmingham, UK

  3. 3

    University of Manchester, Health Methodology Research Group, Salford, UK

  4. 4

    McMaster University, Department of Obstetrics and Gynaecology, Hamilton, Ontario, Canada

*Patrick Vandekerckhove, IOW Healthcare NHS Trust, St Mary's Hospital, Parkhurst Road, Newport, Isle of Wight, PO30 5TG, UK.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 21 OCT 1996


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.